Sanofi

E133715

Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (8)

Statements (50)

Predicate Object
instanceOf multinational corporation
pharmaceutical company
public company
collaboratesWith GlaxoSmithKline
surface form: GSK

Regeneron Pharmaceuticals
coreBusiness consumer healthcare products
prescription medicines
vaccines
country France
formerlyKnownAs Sanofi self-linksurface differs
surface form: Sanofi-Aventis
foundedBy Elf Aquitaine
Total
hasBrand Allegra
Aubagio
Tylenol
surface form: Doliprane

Dupixent
insulin
surface form: Lantus

Plavix
hasDivision Consumer Healthcare
General Medicines
Sanofi self-linksurface differs
surface form: Sanofi Vaccines

Specialty Care
headquartersLocation Paris
inception 1973
industry biotechnology industry
consumer healthcare
healthcare industry
pharmaceutical industry
vaccine industry
legalForm société anonyme
numberOfEmployees over 90,000
productType biological products
over-the-counter medicines
pharmaceutical drugs
vaccines
researchFocus biologics
immuno-oncology
vaccinology
scopeOfOperations worldwide
stockExchangeListing Euronext
surface form: Euronext Paris
stockIndexMembership CAC 40
subsidiary Genzyme
Sanofi self-linksurface differs
surface form: Sanofi Consumer Healthcare

Sanofi self-linksurface differs
surface form: Sanofi Pasteur
therapeuticArea cardiovascular diseases
diabetes
immunology
oncology
rare diseases
tickerSymbol SAN

Referenced by (14)

Full triples — surface form annotated when it differs from this entity's canonical label.

CAC 40 hasComponent Sanofi
Sanofi formerlyKnownAs Sanofi self-linksurface differs
this entity surface form: Sanofi-Aventis
Sanofi subsidiary Sanofi self-linksurface differs
this entity surface form: Sanofi Pasteur
Sanofi subsidiary Sanofi self-linksurface differs
this entity surface form: Sanofi Consumer Healthcare
Sanofi hasDivision Sanofi self-linksurface differs
this entity surface form: Sanofi Vaccines
BioNTech hasCollaboration Sanofi
Hoechst successor Sanofi
this entity surface form: Aventis
Hoechst successor Sanofi
this entity surface form: Sanofi (via mergers)
rimonabant developedBy Sanofi
this entity surface form: Sanofi-Aventis
Marion Laboratories hasSuccessor Sanofi
this entity surface form: Sanofi (through subsequent mergers)
Ambien developer Sanofi